Nyxoah Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Nyxoah's earnings have been declining at an average annual rate of -39.1%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 60.6% per year.

Anahtar bilgiler

-39.1%

Kazanç büyüme oranı

-24.1%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi12.3%
Gelir büyüme oranı60.6%
Özkaynak getirisi-36.2%
Net Marj-908.5%
Sonraki Kazanç Güncellemesi06 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

It's Probably Less Likely That Nyxoah S.A.'s (EBR:NYXH) CEO Will See A Huge Pay Rise This Year

Jun 05
It's Probably Less Likely That Nyxoah S.A.'s (EBR:NYXH) CEO Will See A Huge Pay Rise This Year

Rock star Growth Puts Nyxoah (EBR:NYXH) In A Position To Use Debt

Jan 24
Rock star Growth Puts Nyxoah (EBR:NYXH) In A Position To Use Debt

Do Insiders Own Lots Of Shares In Nyxoah S.A. (EBR:NYXH)?

Dec 21
Do Insiders Own Lots Of Shares In Nyxoah S.A. (EBR:NYXH)?

Gelir ve Gider Dağılımı

Nyxoah nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

ENXTBR:NYXH Gelir, gider ve kazançlar (EUR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 245-442229
31 Mar 245-432228
31 Dec 234-432227
30 Sep 234-462224
30 Jun 233-442222
31 Mar 233-362018
31 Dec 223-311916
30 Sep 222-241715
30 Jun 222-271714
31 Mar 221-291714
31 Dec 211-281512
30 Sep 211-251310
30 Jun 210-21128
31 Mar 210-1695
31 Dec 200-1292
30 Sep 200-873
30 Jun 200-562
31 Mar 200-452
31 Dec 190-442
31 Dec 180-934

Kaliteli Kazançlar: NYXH is currently unprofitable.

Büyüyen Kar Marjı: NYXH is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NYXH is unprofitable, and losses have increased over the past 5 years at a rate of 39.1% per year.

Büyüme Hızlandırma: Unable to compare NYXH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: NYXH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).


Özkaynak Getirisi

Yüksek ROE: NYXH has a negative Return on Equity (-36.24%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin